Skip to content
naulon

Not checkedNot checked for notices yet.

The Synthesis and Preliminary Anticancer Evaluation of 6-Mercaptopurine -Methotrexate Conjugate as Possible Mutual Prodrug

Asmaa Safwan Al-darraji, Mohamed H.Mohamed

Iraqi Journal of Pharmaceutical Sciences · 2019

doi:10.31351/vol28iss1pp114-124 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Small molecules drug conjugate mutual prodrug design (SMDC) composed of folate &lethal agent conjugate , rigidly bonded via hydrophilic bridge& self immolative disulfide bond ; represent new interesting approaches for cancer treatment , the component of SMDC intended to be as possible suit targeted folate receptor , along with greater conservation of component until reaching targeting tumor tissue . The designing & synthesis of compound VI & IIX derived from 6-MP & MTX conjugate altogether as mutual prodrug were processed forward successfully by multiple steps procedure , and by TLC spectrophotometry preliminary analysis assess in detection of products & their intermediate , along with their purity . The structure of two final compounds & their intermediate were proclaimed by melting point measurement , infrared spectrometry & HNMR analysis given results greatly correspond with theoretical proposed chemical structure of synthesized compounds . Furthermore anticancer evaluation on cell line level had been done for two final compound against MCF-7& SKO-3 types of cancer cell & the result were confirmed which show greater cytotoxic tumor activity of two final compound ,while compound IIX possess optimal activity proportional with increase number of 6-MP residue .

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.